Top

European Journal of Nuclear Medicine and Molecular Imaging

Published in:

01-02-2020 | Alzheimer's Disease | Editorial

A future for PET imaging in Alzheimer’s disease

Authors: Aurélie Kas, Raffaella Migliaccio, Bertrand Tavitian

Published in: European Journal of Nuclear Medicine and Molecular Imaging | Issue 2/2020

Excerpt

Alzheimer’s disease is defined neuropathologically by abnormal extra-cellular β-amyloid plaques combined with intraneuronal tau aggregation (neurofibrillary tangles). Observations showing that patients with different clinical presentations and evolutions share the same neuropathological features have led to the notion of an Alzheimer’s disease spectrum encompassing typical and atypical forms of Alzheimer’s disease [1, 2]. …

Alladi S, Xuereb J, Bak T, Nestor P, Knibb J, Patterson K, et al. Focal cortical presentations of Alzheimer’s disease. Brain. 2007;130:2636–45.CrossRef

Mendez MF. Early-onset Alzheimer disease and its variants: CONTINUUM: Lifelong Learning in Neurology. 2019;25:34–51.

Murray ME, Graff-Radford NR, Ross OA, Petersen RC, Duara R, Dickson DW. Neuropathologically defined subtypes of Alzheimer’s disease with distinct clinical characteristics: a retrospective study. Lancet Neurol. 2011;10:785–96.CrossRef

McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR, Kawas CH, et al. The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 2011;7:263–9.CrossRef

Dubois B, Feldman HH, Jacova C, Hampel H, Molinuevo JL, Blennow K, et al. Advancing research diagnostic criteria for Alzheimer’s disease: the IWG-2 criteria. Lancet Neurol. 2014;13:614–29.CrossRef

Bera G, Migliaccio R, Michelin T, Lamari F, Ferrieux S, Nogues M, et al. Parietal involvement in the semantic variant of primary progressive aphasia with Alzheimer’s disease cerebrospinal fluid profile. J Alzheimers Dis. 2018.

Lee SE, Rabinovici GD, Mayo MC, Wilson SM, Seeley WW, DeArmond SJ, et al. Clinicopathological correlations in corticobasal degeneration. Ann Neurol. 2011;70:327–40.CrossRef

Warren JD, Fletcher PD, Golden HL. The paradox of syndromic diversity in Alzheimer disease. Nat Rev Neurol. 2012 [cited 2013 Aug 29]; Available from: http://www.nature.com/doifinder/10.1038/nrneurol.2012.135

Buckner RL, Sepulcre J, Talukdar T, Krienen FM, Liu H, Hedden T, et al. Cortical hubs revealed by intrinsic functional connectivity: mapping, assessment of stability, and relation to Alzheimer’s disease. J Neurosci. 2009;29:1860–73.CrossRef

10.

Migliaccio R, Gallea C, Kas A, Perlbarg V, Samri D, Trotta L, et al. Functional connectivity of ventral and dorsal visual streams in posterior cortical atrophy. J Alzheimers Dis. 2016;51:1119–30.CrossRef

11.

Lehmann M, Madison C, Ghosh PM, Miller ZA, Greicius MD, Kramer JH, et al. Loss of functional connectivity is greater outside the default mode network in nonfamilial early-onset Alzheimer’s disease variants. Neurobiol Aging. 2015;36:2678–86.CrossRef

12.

de Souza LC, Corlier F, Habert M-O, Uspenskaya O, Maroy R, Lamari F, et al. Similar amyloid-β burden in posterior cortical atrophy and Alzheimer’s disease. Brain. 2011;134:2036–43.CrossRef

13.

Ossenkoppele R, Rabinovici GD, Smith R, Cho H, Schöll M, Strandberg O, et al. Discriminative accuracy of [18F]flortaucipir positron emission tomography for Alzheimer disease vs other neurodegenerative disorders. JAMA. 2018;320:1151–62.CrossRef

14.

Ossenkoppele R, Schonhaut DR, Schöll M, Lockhart SN, Ayakta N, Baker SL, et al. Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer’s disease. Brain. 2016;139:1551–67.CrossRef

15.

Sala A, Caprioglio C, Santangelo R, Vanoli EG, Iannaccone S, Magnani G, et al. Brain metabolic signatures across the Alzheimer’s disease spectrum. Eur J Nucl Med Mol Imaging. 2019; (in press).

16.

Migliaccio R, Agosta F, Rascovsky K, Karydas A, Bonasera S, Rabinovici GD, et al. Clinical syndromes associated with posterior atrophy: early age at onset AD spectrum. Neurology. 2009;73:1571–8.CrossRef

17.

Sintini I, Martin PR, Graff-Radford J, Senjem ML, Schwarz CG, Machulda MM, et al. Longitudinal tau-PET uptake and atrophy in atypical Alzheimer’s disease. NeuroImage Clin. 2019;23:101823.CrossRef

18.

Firth NC, Primativo S, Marinescu R-V, Shakespeare TJ, Suarez-Gonzalez A, Lehmann M, et al. Longitudinal neuroanatomical and cognitive progression of posterior cortical atrophy. Brain. 2019;142:2082–95.CrossRef

19.

Vanhoutte M, Semah F, Leclerc X, Sillaire AR, Jaillard A, Kuchcinski G, et al. Three-year changes of cortical 18F-FDG in amnestic vs. non-amnestic sporadic early-onset Alzheimer’s disease. Eur J Nucl Med Mol Imaging. 2019; Available from: http://link.springer.com/10.1007/s00259-019-04519-w.

20.

Migliaccio R, Federica A, Basaia S, Cividini C, Habert MO, Kas A, et al. Functional brain connectome in posterior cortical atrophy. Neuroimage Clin. in press.

Title: A future for PET imaging in Alzheimer’s disease
Authors: Aurélie Kas
Raffaella Migliaccio
Bertrand Tavitian
Publication date: 01-02-2020
Publisher: Springer Berlin Heidelberg
Keywords: Alzheimer's Disease
Alzheimer's Disease
Published in: European Journal of Nuclear Medicine and Molecular Imaging / Issue 2/2020
Print ISSN: 1619-7070
Electronic ISSN: 1619-7089
DOI: https://doi.org/10.1007/s00259-019-04640-w

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

A future for PET imaging in Alzheimer’s disease

Excerpt

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 2/2020

Head-to-head comparison of tau positron emission tomography tracers [18F]flortaucipir and [18F]RO948

Characterization of the serotonin 2A receptor selective PET tracer (R)-[18F]MH.MZ in the human brain

The clinical feasibility of deep learning-based classification of amyloid PET images in visually equivocal cases

Suboptimal validity of amyloid imaging-based diagnosis and management of Alzheimer’s disease: why it is time to abandon the approach

Incremental value of amyloid-PET versus CSF in the diagnosis of Alzheimer’s disease

Age-associated reorganization of metabolic brain connectivity in Chinese children